Cassava Sciences | PTIE - Trade Debtors


Cassava Sciences reported $817K in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Abbott USD 10.4B 166M Sep/2025
Amgen USD 9.57B 1.08B Dec/2025
Biogen USD 1.85B 234M Sep/2025
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Cassava Sciences USD 817K 18K Sep/2025
Eisai JPY 249.06B 25B Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Geron USD 37.66M 1.71M Sep/2025
J&J USD 17.61B 235M Sep/2025
Merck USD 12.12B 596M Sep/2025
Novartis USD 8.98B 192M Sep/2025
Novavax USD 94.96M 62.81M Sep/2024
Pfizer USD 18.12B 2.02B Sep/2025
Roche Holding CHF 11.9B 460M Dec/2025